Appropriate Integration of Radiotherapy in Cancer Care: A Call to Action From Researchers

Share this content:
A report highlights the current gap in the utilization of radiotherapy in Europe and outlines an action plan as a solution.
A report highlights the current gap in the utilization of radiotherapy in Europe and outlines an action plan as a solution.

A report has highlighted the current gap in the utilization of radiotherapy for cancer patients in Europe and outlined a 5 point action plan that may close the gap.1 The paper was commissioned by the Marie Curie Legacy Campaign, which is an initiative of the European Society for Radiotherapy and Oncology (ESTRO) and the ESTRO Cancer Foundation. 

Currently, radiotherapy is recommended for more than half of patients with cancer but a quarter of patients who need radiotherapy as part of their treatment do not receive it. The reasons for the underutilization of radiotherapy include lack of inclusion in health policy agendas, high-quality equipment, and trained personnel.

Continue Reading Below

The authors drafted a 5 point action plan aims to close this gap.

In order to close the gap, the authors suggest 5 points of action. For one, the report authors indicate that governments and policy makers must “make radiotherapy a central component of cancer care in policies, planning and budgets.” Second, professional societies working with European Union-level and national decision-makers are asked to “achieve recognition of all radiotherapy professions and harmonise education and training standards across Europe.” Third, European Union and national research and innovation funds and the research community are asked to “invest in research and use of data to continuously improve radiotherapy outcomes for patients and maximise the potential of innovation.” Fourth, multidisciplinary cancer care teams are asked to “fully integrate radiotherapy into treatment planning and decision-making.” The final action point asks patient groups, media, and other stakeholders to “help improve general understanding of radiotherapy to ensure it can achieve its full potential for patient care.”

“We call on all stakeholders, with policymakers at the helm, to help position radiotherapy appropriately within cancer policies and models of care – for the benefit of cancer patients today and tomorrow,” the report authors concluded.

Reference

  1. Kazmierska J, Jornet Sala N, Leech M, Jereczek-Fossa BA, Lievens Y, Yarnold J. Radiotherapy: seizing the opportunity in cancer care. https://mariecurielegacy.org/wp-content/uploads/2018/11/Radiotherapy_seizing_the_opportunity_in_cancer_care.pdf. Published November 2018. Accessed November 12, 2018.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs